Remedy'sRx Revenue and Competitors
Estimated Revenue & Valuation
- Remedy'sRx's estimated annual revenue is currently $15M per year.
- Remedy'sRx's estimated revenue per employee is $74,627
Employee Data
- Remedy'sRx has 201 Employees.
Remedy'sRx's People
Name | Title | Email/Phone |
---|---|---|
1 | Pharmacy Manager | Reveal Email/Phone |
What Is Remedy'sRx?
At Remedy’sRx®, we know precisely what today’s customers and owners want. It’s that understanding that has made us the fastest-growing independent pharmacy network in Canada. Our revolutionary approach helps independent pharmacies compete against the large chain stores without giving up the small but important details that make them unique. In a highly competitive and rapidly changing marketplace, we’re creating a brighter future for independents. How do we do it? Our programs–which include a best-in-class Signature Program, cutting-edge pharmacy services and technology, innovative tools, store design, real estate, financial management, private label and merchandising support–help owners modernize their operations and provide their customers with better care. If you want to deliver more to your customers while maximizing your profitability, talk to us about joining the Remedy’sRx® family today.
keywords:N/AN/A
Total Funding
201
Number of Employees
$15M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Remedy'sRx News
Strong demand from therapists and patients for treatments involving ... Partnered with SRx Health Solutions and BioScript Solutions to Build Out a Network...
... IDA, The Medicine Shoppe, Remedy'sRx, and Pharmasave. In 2021 the platform enabled pharmacies administer more than 544,000 flu shots,...
General Motors further states that a remedy is under development, ... twinned with the Chevrolet Equinox, Cadillac SRX, and the Saab 9-4X.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $50.2M | 201 | 26% | N/A |
#2 | $7.5M | 201 | -5% | N/A |
#3 | $39.8M | 201 | 6% | N/A |
#4 | $15M | 201 | 12% | N/A |
#5 | $39.8M | 201 | -3% | N/A |